Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock

41.125 EUR
-0.32 (-0.77%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to QIA. QIA was compared to 19 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA is not valued too expensively and it also shows a decent growth rate. These ratings could make QIA a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
QIA had positive earnings in each of the past 5 years.
QIA had a positive operating cash flow in each of the past 5 years.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of QIA (6.19%) is better than 68.42% of its industry peers.
The Return On Equity of QIA (11.11%) is better than 68.42% of its industry peers.
The Return On Invested Capital of QIA (7.44%) is better than 63.16% of its industry peers.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is in line with the industry average of 7.47%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of QIA (19.58%) is better than 94.74% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 27.02%, QIA belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
QIA's Gross Margin of 64.10% is amongst the best of the industry. QIA outperforms 94.74% of its industry peers.
QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
Compared to 1 year ago, QIA has less shares outstanding
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.58 indicates that QIA is not in any danger for bankruptcy at the moment.
QIA's Altman-Z score of 3.58 is fine compared to the rest of the industry. QIA outperforms 68.42% of its industry peers.
The Debt to FCF ratio of QIA is 4.50, which is a neutral value as it means it would take QIA, 4.50 years of fcf income to pay off all of its debts.
QIA's Debt to FCF ratio of 4.50 is fine compared to the rest of the industry. QIA outperforms 73.68% of its industry peers.
QIA has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, QIA is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.58
ROIC/WACC0.95
WACC7.8%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.60 indicates that QIA has no problem at all paying its short term obligations.
QIA has a better Current ratio (2.60) than 100.00% of its industry peers.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a Quick ratio of 2.30. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.62% over the past year.
The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
QIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

The Earnings Per Share is expected to grow by 9.54% on average over the next years. This is quite good.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y9.54%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

QIA is valuated rather expensively with a Price/Earnings ratio of 20.06.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
QIA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.33, which indicates a rather expensive current valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, QIA is valued a bit cheaper.
Industry RankSector Rank
PE 20.06
Fwd PE 18.33
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

QIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QIA is cheaper than 68.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIA is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.83
EV/EBITDA 13.9
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.35
PEG (5Y)2.39
EPS Next 2Y8.08%
EPS Next 3Y8.5%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is a higher than the industry average which is at 0.70.
With a Dividend Yield of 0.52, QIA pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (11/28/2025, 7:00:00 PM)

41.125

-0.32 (-0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/dmh
Earnings (Next)02-03 2026-02-03/amc
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.92B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target44.49 (8.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.61%
PT rev (3m)-1.6%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 20.06
Fwd PE 18.33
P/S 4.98
P/FCF 21.83
P/OCF 15.68
P/B 2.83
P/tB 12.93
EV/EBITDA 13.9
EPS(TTM)2.05
EY4.98%
EPS(NY)2.24
Fwd EY5.46%
FCF(TTM)1.88
FCFY4.58%
OCF(TTM)2.62
OCFY6.38%
SpS8.26
BVpS14.55
TBVpS3.18
PEG (NY)2.35
PEG (5Y)2.39
Graham Number25.91
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROCE 10.03%
ROIC 7.44%
ROICexc 10.67%
ROICexgc 39.98%
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
FCFM 22.82%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Debt/EBITDA 2.17
Cap/Depr 97.52%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 87.76%
Profit Quality 116.56%
Current Ratio 2.6
Quick Ratio 2.3
Altman-Z 3.58
F-Score8
WACC7.8%
ROIC/WACC0.95
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y9.54%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%

QIAGEN N.V. / QIA.DE FAQ

What is the fundamental rating for QIA stock?

ChartMill assigns a fundamental rating of 7 / 10 to QIA.DE.


What is the valuation status of QIAGEN N.V. (QIA.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a profitability rating of 8 / 10.


What is the valuation of QIAGEN N.V. based on its PE and PB ratios?

The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 20.06 and the Price/Book (PB) ratio is 2.83.


How financially healthy is QIAGEN N.V.?

The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.